ORPHAN TECHNOLOGIES
Orphan Technologies is committed to reduce the burden of patients suffering from homocystinuria. OT-58, their lead drug development candidate, has been optimized as an enzyme replacement therapy for classical homocystinuria, a genetic disease characterized by debilitating cardiovascular, skeletal, neurologic, and ophthalmologic complications. OT-58 is designed to reduce homocysteine levels via a targeted mechanism of action and may have therapeutic applications in other diseases.
ORPHAN TECHNOLOGIES
Industry:
Therapeutics
Address:
Rapperswil, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.orphantechnologies.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Amazon Google Apps For Business ReCAPTCHA GoDaddy DNS ReCAPTCHA V2 Amazon Frankfurt Region Media Temple
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Official Site Inspections
http://www.orphantechnologies.com
- Host name: acsmekekqc.gs10.mtsvc.net
- IP address: 64.207.139.130
- Location: Culver City United States
- Latitude: 34.0141
- Longitude: -118.3983
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90232
